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Exercise Release of Cardiac Natriuretic
Peptides Is Markedly Enhanced When
Patients With Coronary Artery Disease
Are Treated Medically by Beta-Blockers
We read with interest the recent study by Marie et al. (1),
which concluded that patients with chronic coronary artery
disease exhibited much higher exercise release of (ANP) and
brain natriuretic peptide (BNP) when they were treated
with beta-blockers. Exercise-related increase in natriuretic
peptides had been reported across a majority of patients
undergoing exercise treadmill test for evaluation of ischemic
heart disease (2–5). The investigators postulated that the
mechanisms of enhanced natriuretic peptide release second-
ary to beta-blockade may be related to exercise-induced
increase in wall tension and cavity size. However, the
researchers did not report the presence of reversible isch-
emia among the patients who were receiving beta-blocker
therapy.
We recently reported (6) that exercise-induced increase in
B-type natriuretic peptide was more prominent in patients
with evidence of reversible ischemia on single-photon emis-
sion computed tomography (SPECT). It is therefore pos-
sible that the presence of exercise-induced reversible isch-
emia may serve as a confounding factor in this patient
population, and we wonder whether the BNP rise among
patients receiving beta-blockers during exercise is significant
if the data are adjusted for presence of reversible ischemia.
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REPLY
When we started our study, we hoped that an enhanced
secretion of atrial natriuretic peptide (ANP) and/or brain
natriuretic peptide (BNP) might allow for detecting exercise
ischemia. However, as it was already pointed out in our
report, myocardial ischemia was documented by exercise-
single-photon emission computed tomography (SPECT) in
63 of our 104 patients with coronary artery disease, and this
ischemia was not a predictor of the exercise increase in
blood levels of either ANP or BNP (1). More precisely, in
the 63 patients with SPECT-ischemia, the difference be-
tween exercise and rest concentrations of BNP was, on
average, 14  20 ng/l. Equivalent values were observed in
patients with normal SPECT: 14  35 ng/l. By contrast,
much higher values were observed in the remaining patients
showing SPECT-necrosis: 49  55 ng/l (p  0.001).
As it was already discussed in our study (1), this is mainly
an acute release of peptides from secretory granules that is
likely to allow a prompt exercise rise in the blood concen-
trations of peptides. Therefore, this rise depends on 1) the
amount of peptides, which may be previously stored within
secretory granules, and 2) the mechanism of peptides release
from these granules.
Granule storage is known to rise in parallel to the resting
blood concentrations of natriuretic peptides and to the level
of left ventricular dysfunction. This is presumably the reason
why we found that the rest concentration of peptides was a
main predictor of the exercise increase in peptide concen-
tration. For both ANP and BNP, however, rest concentra-
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